MISSION
Science
that becomes medicine
VISION
PrimeCell team is working 15 years to discover technologies
to treat unmedical needs of civilisation.
STRATEGY
PrimeCell is the bio-med company focusing on discovering and clinical testing of biological drugs and medicinal technologies, which are changing genes and cells parameters to support regeneration of human tissueas and organs.
We are proud to our results
in regenerative medicine
PATIENTS
SQM OF OUR LABS IN EU
RESEARCH PROJECTS
CORE EMPLOYEES
NEWS
Three years after raising $450M, Andreessen is back with a new $750M life sciences fund
TechCrunch – Life sciences is big business in venture capital land and firms are raising big dollars to find the companies that will lead the next healthcare revolution. Chief among[…]
Read more
Primecell’s immuno-oncology platform uses its proprietary pyroptosis technology to fight cancer
Primecell’s immuno-oncology and immuno-infectious platform uses its proprietary pyroptosis technology to induce tumor cell and pathogen death via immune activation (innate and adaptive) with immune memory surveillance. Primecell has two[…]
Read more
4MEDi – Český vědec opustil Cambridge, aby vedl tým v Ostravě. V buněčné terapii jsou špička
Aktuálně.cz – Vědec Michal Šimíček (34) působil několik let na věhlasném pracovišti v Cambridge, pak se ale vrátil na rodnou severní Moravu. V Ostravě založil centrum, kde zkoumají možnost léčby[…]
Read moreCo-operative transfer research
PrimeCell leads co-operative transfer research with prestigious Universities, Science institutions and technology companies around the world.
